Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 12, 2011 - Issue 17
Submit an article Journal homepage
479
Views
20
CrossRef citations to date
0
Altmetric
Original Research

The effects of rosuvastatin alone or in combination with fenofibrate or omega 3 fatty acids on inflammation and oxidative stress in patients with mixed dyslipidemia

Aris P AgouridisUniversity of Ioannina Medical School, Department of Internal Medicine, 45110 Ioannina, Greece+30 26510 07509; +30 26510 07016; [email protected]
,
Vasilis TsimihodimosUniversity of Ioannina Medical School, Department of Internal Medicine, 45110 Ioannina, Greece+30 26510 07509; +30 26510 07016; [email protected]
, MD,
Theodosios D FilippatosUniversity of Ioannina Medical School, Department of Internal Medicine, 45110 Ioannina, Greece+30 26510 07509; +30 26510 07016; [email protected]
,
Andromachi A DimitriouUniversity of Ioannina, Department of Chemistry, Laboratory of Biochemistry, 45110 Ioannina, Greece
,
Costantinos C TellisUniversity of Ioannina, Department of Chemistry, Laboratory of Biochemistry, 45110 Ioannina, Greece
,
Moses S ElisafUniversity of Ioannina Medical School, Department of Internal Medicine, 45110 Ioannina, Greece+30 26510 07509; +30 26510 07016; [email protected]
,
Dimitri P MikhailidisUniversity College London, University College London Medical School, Royal Free Hospital Campus, Department of Clinical Biochemistry (Vascular Disease Prevention Clinics), NW3 2QG London, UK
&
Alexandros D TselepisUniversity of Ioannina, Department of Chemistry, Laboratory of Biochemistry, 45110 Ioannina, Greece
 show all
Pages 2605-2611 | Published online: 29 Jun 2011

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

M. Ruscica, N. Ferri, C. Macchi, A. Corsini & C. R. Sirtori. (2018) Lipid lowering drugs and inflammatory changes: an impact on cardiovascular outcomes?. Annals of Medicine 50:6, pages 461-484.
Read now
T. D. Filippatos, M. Florentin, M. Georgoula & M. S. Elisaf. (2017) Pharmacological management of diabetic dyslipidemia. Expert Review of Clinical Pharmacology 10:2, pages 187-200.
Read now
Theodosios D Filippatos & Moses S Elisaf. (2015) Safety considerations with fenofibrate/simvastatin combination. Expert Opinion on Drug Safety 14:9, pages 1481-1493.
Read now
Theodosios D Filippatos, Vasilios G Athyros & Moses S Elisaf. (2014) The pharmacokinetic considerations and adverse effects of DDP-4 inhibitors. Expert Opinion on Drug Metabolism & Toxicology 10:6, pages 787-812.
Read now

Articles from other publishers (16)

Ping Yan, Jing Cao, Yajun Zhou, Xia Zhou, Zhongwu Sun & Xiaoqun Zhu. (2022) Serum levels of sLOX‐1 and Lp‐PLA2 can predict the prognosis of acute cerebral infarction with a high specificity. Physiological Reports 10:1.
Crossref
Massimiliano Ruscica, Alberto Corsini, Nicola Ferri, Maciej Banach & Cesare R. Sirtori. (2020) Clinical approach to the inflammatory etiology of cardiovascular diseases. Pharmacological Research 159, pages 104916.
Crossref
Eleni Pappa, Christos V. Rizos, Theodosios D. Filippatos & Moses S. Elisaf. (2019) Emerging Fixed-Dose Combination Treatments for Hyperlipidemia. Journal of Cardiovascular Pharmacology and Therapeutics 24:4, pages 315-322.
Crossref
Theodosios D. Filippatos, Anastazia Kei, Christos V. Rizos & Moses S. Elisaf. (2017) Effects of PCSK9 Inhibitors on Other than Low-Density Lipoprotein Cholesterol Lipid Variables. Journal of Cardiovascular Pharmacology and Therapeutics 23:1, pages 3-12.
Crossref
Mabel Toribio, Kathleen V. Fitch, Laura Sanchez, Tricia H. Burdo, Kenneth C. Williams, Craig A. Sponseller, Mary McCurdy Pate, Judith A. Aberg, Markella V. Zanni & Steven K. Grinspoon. (2017) Effects of pitavastatin and pravastatin on markers of immune activation and arterial inflammation in HIV. AIDS 31:6, pages 797-806.
Crossref
Amirhossein Sahebkar, Anna Hernández-Aguilera, David Abelló, Elena Sancho, Jordi Camps & Jorge Joven. (2016) Systematic review and meta-analysis deciphering the impact of fibrates on paraoxonase-1 status. Metabolism 65:5, pages 609-622.
Crossref
Richard S. Castaldo. (2016) Switching statin-treated patients from fenofibrate to the prescription omega-3 therapy icosapent ethyl: a retrospective case series. Drugs & Therapy Perspectives 32:4, pages 162-169.
Crossref
Qiankun Zhu, Guizhen He, Jie Wang, Yukang Wang & Wei Chen. (2016) Protective effects of fenofibrate against acute lung injury induced by intestinal ischemia/reperfusion in mice. Scientific Reports 6:1.
Crossref
Gianna Ferretti, Tiziana Bacchetti & Amirhossein Sahebkar. (2015) Effect of statin therapy on paraoxonase-1 status: A systematic review and meta-analysis of 25 clinical trials. Progress in Lipid Research 60, pages 50-73.
Crossref
Stephen P Adams, Sarpreet S Sekhon & James M Wright. (2014) Rosuvastatin for lowering lipids. Cochrane Database of Systematic Reviews 2017:1.
Crossref
Anastazia Kei, Constantinos Tellis, Evangelos Liberopoulos, Alexandros Tselepis & Moses Elisaf. (2014) Effect of Switch to the Highest Dose of Rosuvastatin Versus Add-on-Statin Fenofibrate Versus Add-on-Statin Nicotinic Acid/Laropiprant on Oxidative Stress Markers in Patients with Mixed Dyslipidemia. Cardiovascular Therapeutics 32:4, pages 139-146.
Crossref
Elisavet Moutzouri, Evangelos N. Liberopoulos, Constantinos C. Tellis, Haralambos J. Milionis, Alexandros D. Tselepis & Moses S. Elisaf. (2013) Comparison of the effect of simvastatin versus simvastatin/ezetimibe versus rosuvastatin on markers of inflammation and oxidative stress in subjects with hypercholesterolemia. Atherosclerosis 231:1, pages 8-14.
Crossref
Alessio Arrivi, Gaetano Tanzilli, Paolo Emilio Puddu, Luca Iannucci & Enrico Mangieri. (2013) Rosuvastatin was Effective in Acute Heart Failure and Slow Coronary Flow: A Hypothesis-generating Case Report. The Open Cardiovascular Medicine Journal 7:1, pages 12-15.
Crossref
A. P. Agouridis, M. S. Kostapanos, V. Tsimihodimos, C. Kostara, D. P. Mikhailidis, E. T. Bairaktari, A. D. Tselepis & M. S. Elisaf. (2012) Effect of rosuvastatin monotherapy or in combination with fenofibrate or ω-3 fatty acids on lipoprotein subfraction profile in patients with mixed dyslipidaemia and metabolic syndrome. International Journal of Clinical Practice 66:9, pages 843-853.
Crossref
Anastazia A. Kei, Theodosios D. Filippatos, Vasilios Tsimihodimos & Moses S. Elisaf. (2012) A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease. Metabolism 61:7, pages 906-921.
Crossref
I. Kouroumichakis, N. Papanas, P. Zarogoulidis, V. Liakopoulos, E. Maltezos & D.P. Mikhailidis. (2012) Fibrates: Therapeutic potential for diabetic nephropathy?. European Journal of Internal Medicine 23:4, pages 309-316.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.